Physician
Permanente Medical Group INC
Permanente Medical Group INC was paid $125.88M by Medicaid between Jan 2018 and Dec 2024, across 607 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 12% of everything it billed.
33Billing provider infoPERMANENTE MEDICAL GROUP INC
STOCKTON, CA 95210
STOCKTON, CA 95210
33aNPI1548343510assigned 10/23/2006
33bProvider typeSurgery Physician
28Total paid$125.88M
24GClaims4,998,449
24DCodes billed607
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in California
Rank by total paid#1 of 437
Median peer was paid$23K
This provider vs. median5,505×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 643,012 | $1.19M | |
| 2019 | 672,908 | $2.09M | |
| 2020 | 403,159 | $6.57M | |
| 2021 | 663,503 | $14.45M | |
| 2022 | 756,414 | $17.55M | |
| 2023 | 890,085 | $32.40M | |
| 2024incomplete | 969,368 | $51.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 478,971 | 455,465 | $15.44M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 109,174 | 107,664 | $15.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 223,557 | 220,587 | $13.15M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 157,218 | 149,781 | $5.70M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.1% | 84,089 | 49,574 | $5.18M |
| 91320 | 3.6% | 31,250 | 31,237 | $4.47M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.4% | 34,802 | 32,330 | $4.25M |
| 90962 | 2.7% | 9,094 | 8,987 | $3.42M | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 130,040 | 128,271 | $3.12M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 200,342 | 189,371 | $2.75M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 43,924 | 40,919 | $2.54M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.9% | 52,193 | 50,230 | $2.38M |
595 more codes
| G0008 | Administration of influenza virus vaccine | 1.8% | 240,586 | $2.25M |
| 90480 | 1.7% | 47,076 | $2.14M | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 12,088 | $1.72M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.2% | 229,245 | $1.49M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 44,277 | $1.45M |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 124,341 | $1.40M |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 1.0% | 904 | $1.30M |
| 90662 | <1% | 16,118 | $1.12M | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 17,623 | $1.08M |
| 92015 | Determination of refractive state | <1% | 154,874 | $1.04M |
| 0001A | <1% | 25,018 | $959K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 5,180 | $951K |
| 0002A | <1% | 23,984 | $948K | |
| 71045 | Radiologic examination, chest; single view | <1% | 138,275 | $947K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 10,441 | $890K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 628 | $888K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,760 | $783K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 7,735 | $746K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 6,182 | $656K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 19,906 | $630K |
| 90686 | <1% | 195,854 | $605K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 21,745 | $605K |
| 99442 | <1% | 9,505 | $594K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,285 | $549K |
| 77080 | <1% | 13,792 | $518K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 11,550 | $494K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 41,940 | $488K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 22,605 | $476K |
| 0124A | <1% | 11,543 | $474K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 5,793 | $472K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 37,526 | $447K |
| 92134 | <1% | 12,029 | $445K | |
| 90378 | <1% | 380 | $436K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 182,464 | $433K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,577 | $431K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,121 | $429K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 30,496 | $421K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 21,451 | $415K |
| 0064A | <1% | 10,237 | $412K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 29,386 | $401K |
| 0054A | <1% | 9,221 | $380K | |
| 0012A | <1% | 9,738 | $378K | |
| 90837 | Psychotherapy session, about an hour | <1% | 13,725 | $375K |
| 92250 | <1% | 13,233 | $371K | |
| 0071A | <1% | 9,032 | $361K | |
| 0072A | <1% | 8,790 | $351K | |
| 73630 | <1% | 30,485 | $350K | |
| 0011A | <1% | 9,534 | $336K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,640 | $333K |
| 0004A | <1% | 8,103 | $319K | |
| 92002 | <1% | 16,098 | $294K | |
| 90694 | <1% | 4,709 | $291K | |
| 97810 | <1% | 10,956 | $291K | |
| 99441 | <1% | 11,956 | $284K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 108 | $260K |
| 11721 | <1% | 2,309 | $253K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 15,963 | $240K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 3,155 | $233K |
| 91322 | <1% | 1,641 | $232K | |
| 76642 | <1% | 5,679 | $227K | |
| 64615 | <1% | 1,859 | $215K | |
| 76830 | Ultrasound, transvaginal | <1% | 8,947 | $205K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,813 | $198K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 13,194 | $197K |
| 97161 | <1% | 3,896 | $193K | |
| 0134A | <1% | 4,508 | $188K | |
| 90656 | <1% | 27,988 | $179K | |
| 73564 | <1% | 7,955 | $167K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 10,315 | $160K |
| 95800 | <1% | 1,603 | $155K | |
| 73030 | <1% | 8,852 | $153K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,033 | $153K |
| 73610 | <1% | 16,841 | $145K | |
| 92523 | <1% | 2,140 | $140K | |
| 72100 | <1% | 6,781 | $136K | |
| 98968 | <1% | 6,501 | $131K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,419 | $130K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 8,055 | $128K |
| 92567 | <1% | 9,271 | $127K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,371 | $126K |
| 92557 | <1% | 2,614 | $120K | |
| 73130 | <1% | 11,185 | $120K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 8,889 | $117K |
| 0031A | <1% | 2,927 | $116K | |
| 99443 | <1% | 1,680 | $115K | |
| 90653 | <1% | 2,194 | $114K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,335 | $113K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 6,794 | $111K |
| 93976 | <1% | 2,084 | $110K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,630 | $108K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 5,958 | $105K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 9,038 | $104K |
| 73110 | <1% | 13,538 | $104K | |
| 90670 | <1% | 12,133 | $102K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,679 | $101K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 7,318 | $99K |
| 11056 | <1% | 475 | $98K | |
| 86580 | <1% | 24,642 | $98K | |
| 71250 | <1% | 475 | $98K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 669 | $96K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 49,410 | $94K |
| 74018 | <1% | 14,749 | $93K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 16,415 | $88K |
| 72141 | <1% | 659 | $84K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 6,059 | $83K |
| 0052A | <1% | 2,031 | $82K | |
| 90682 | <1% | 19,042 | $81K | |
| 91319 | <1% | 2,048 | $80K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,587 | $80K |
| 94729 | <1% | 998 | $78K | |
| 73502 | <1% | 2,850 | $77K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 30,085 | $70K |
| 0051A | <1% | 1,679 | $68K | |
| 73560 | <1% | 7,398 | $66K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 858 | $62K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,140 | $62K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 151 | $59K |
| 73221 | <1% | 338 | $58K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 102 | $57K |
| 99205 | Prolong outpt/office vis | <1% | 867 | $56K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 4,036 | $55K |
| 0154A | <1% | 1,365 | $52K | |
| 70496 | <1% | 392 | $50K | |
| 95117 | <1% | 11,188 | $49K | |
| 93268 | <1% | 139 | $48K | |
| 90710 | <1% | 3,386 | $46K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,065 | $45K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,382 | $44K |
| 90677 | <1% | 1,663 | $44K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 327 | $43K |
| 76770 | <1% | 1,367 | $42K | |
| 70491 | <1% | 437 | $42K | |
| 93000 | <1% | 3,515 | $41K | |
| 97597 | <1% | 586 | $40K | |
| 91200 | <1% | 1,284 | $40K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,731 | $39K |
| 73140 | <1% | 6,089 | $39K | |
| 91318 | <1% | 1,518 | $38K | |
| 94060 | <1% | 639 | $37K | |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | <1% | 13 | $37K |
| 0073A | <1% | 971 | $37K | |
| 73562 | <1% | 1,721 | $35K | |
| 72040 | <1% | 1,928 | $33K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 790 | $33K |
| 70498 | <1% | 227 | $32K | |
| 92526 | <1% | 722 | $30K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 421 | $30K |
| 73080 | <1% | 4,349 | $28K | |
| 0081A | <1% | 733 | $28K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 312 | $26K |
| 90674 | <1% | 2,639 | $25K | |
| 96416 | <1% | 94 | $25K | |
| 88307 | <1% | 678 | $25K | |
| 94726 | <1% | 342 | $25K | |
| 31575 | <1% | 157 | $24K | |
| 0082A | <1% | 643 | $24K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 25 | $23K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 4,793 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 39,295 | $22K |
| 91321 | <1% | 583 | $22K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,810 | $21K |
| 76882 | <1% | 423 | $21K | |
| 0003A | <1% | 530 | $21K | |
| 97811 | <1% | 232 | $19K | |
| 95819 | <1% | 109 | $19K | |
| 93971 | <1% | 1,138 | $18K | |
| 76536 | <1% | 331 | $18K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,832 | $18K |
| 73590 | <1% | 2,603 | $18K | |
| 90648 | <1% | 13,560 | $16K | |
| 90651 | <1% | 5,057 | $16K | |
| 0111A | <1% | 471 | $16K | |
| 90750 | <1% | 1,976 | $15K | |
| 99397 | <1% | 217 | $15K | |
| 72082 | <1% | 991 | $15K | |
| 77066 | Tomosynthesis, mammo | <1% | 145 | $15K |
| 0112A | <1% | 407 | $14K | |
| 99307 | <1% | 837 | $14K | |
| 70486 | <1% | 345 | $14K | |
| 90734 | <1% | 2,893 | $13K | |
| 92133 | <1% | 697 | $13K | |
| 90723 | <1% | 5,126 | $13K | |
| 0013A | <1% | 318 | $13K | |
| 88304 | <1% | 2,108 | $12K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,611 | $12K |
| 90691 | <1% | 944 | $12K | |
| 92504 | <1% | 585 | $12K | |
| 90679 | <1% | 69 | $12K | |
| 52000 | <1% | 25 | $11K | |
| 20610 | <1% | 447 | $11K | |
| 76000 | <1% | 947 | $11K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,795 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,184 | $11K |
| 11055 | <1% | 67 | $10K | |
| 93923 | <1% | 167 | $10K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 158 | $10K |
| G0009 | Administration of pneumococcal vaccine | <1% | 9,323 | $10K |
| 96040 | <1% | 433 | $9K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 978 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 34,687 | $9K |
| 74170 | <1% | 34 | $9K | |
| 11719 | <1% | 334 | $9K | |
| 93296 | <1% | 141 | $9K | |
| 73090 | <1% | 2,107 | $9K | |
| 78451 | <1% | 56 | $9K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,247 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 11,730 | $8K |
| 90633 | <1% | 4,715 | $8K | |
| 93280 | <1% | 27 | $8K | |
| 88342 | <1% | 1,303 | $8K | |
| 98967 | <1% | 495 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 6,927 | $8K |
| 99201 | <1% | 5,031 | $7K | |
| 97165 | <1% | 251 | $7K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 46,773 | $7K |
| 92228 | <1% | 288 | $7K | |
| 70544 | <1% | 38 | $7K | |
| 87506 | <1% | 1,407 | $6K | |
| 95782 | <1% | 39 | $6K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 27 | $6K |
| 92083 | <1% | 368 | $6K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 347 | $6K |
| 72050 | <1% | 200 | $6K | |
| 99385 | <1% | 850 | $6K | |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | <1% | 2,261 | $6K |
| S9480 | Intensive outpatient psychiatric services, per diem | <1% | 994 | $6K |
| 0083A | <1% | 276 | $5K | |
| 20611 | <1% | 40 | $5K | |
| 59025 | Fetal non-stress test | <1% | 1,018 | $5K |
| 92060 | <1% | 229 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $5K |
| 76376 | <1% | 280 | $5K | |
| 94010 | <1% | 133 | $5K | |
| K0001 | Standard wheelchair | <1% | 1,478 | $5K |
| 99386 | <1% | 488 | $4K | |
| 94660 | <1% | 820 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,669 | $4K |
| 43235 | <1% | 12 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13,878 | $4K |
| 0121A | <1% | 251 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 34,305 | $4K |
| 74022 | <1% | 687 | $4K | |
| 84439 | <1% | 8,227 | $4K | |
| 92568 | <1% | 211 | $4K | |
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | <1% | 63 | $4K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 35 | $3K |
| 73120 | <1% | 366 | $3K | |
| 92025 | <1% | 65 | $3K | |
| 72070 | <1% | 189 | $3K | |
| 72081 | <1% | 246 | $3K | |
| 84460 | <1% | 33,820 | $3K | |
| 93015 | <1% | 269 | $3K | |
| 73620 | <1% | 784 | $3K | |
| 51798 | <1% | 129 | $3K | |
| 93970 | <1% | 107 | $3K | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 1,162 | $3K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 118 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13,874 | $3K |
| 93320 | <1% | 72 | $3K | |
| 99221 | <1% | 372 | $3K | |
| 92136 | <1% | 41 | $3K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 19 | $3K |
| 74019 | <1% | 581 | $3K | |
| 99460 | <1% | 1,141 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 86 | $3K |
| 80061 | Lipid panel | <1% | 22,455 | $3K |
| 99173 | <1% | 3,179 | $3K | |
| 97166 | <1% | 79 | $2K | |
| 59840 | <1% | 101 | $2K | |
| 96112 | <1% | 173 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 736 | $2K |
| 97813 | <1% | 195 | $2K | |
| 87631 | <1% | 918 | $2K | |
| 90672 | <1% | 411 | $2K | |
| 97026 | <1% | 234 | $2K | |
| 84450 | <1% | 15,536 | $2K | |
| 83970 | <1% | 2,519 | $2K | |
| 82728 | <1% | 19,493 | $2K | |
| 90785 | <1% | 529 | $2K | |
| 83516 | <1% | 3,065 | $2K | |
| 97533 | <1% | 49 | $2K | |
| 90715 | <1% | 2,613 | $2K | |
| 96417 | <1% | 16 | $2K | |
| 90661 | <1% | 461 | $2K | |
| 82565 | <1% | 36,373 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,456 | $2K |
| 86003 | <1% | 1,676 | $2K | |
| 73552 | <1% | 102 | $2K | |
| 93325 | <1% | 72 | $2K | |
| 88141 | <1% | 970 | $2K | |
| 90681 | <1% | 786 | $2K | |
| T4530 | Pediatric sized disposable incontinence product, brief/diaper, large size, each | <1% | 89 | $2K |
| 73660 | <1% | 195 | $2K | |
| A0425 | Ground mileage, per statute mile | <1% | 1,956 | $2K |
| 86235 | <1% | 379 | $2K | |
| E0570 | Nebulizer, with compressor | <1% | 219 | $2K |
| 92511 | <1% | 12 | $1K | |
| 92550 | <1% | 63 | $1K | |
| 92579 | <1% | 147 | $1K | |
| 80051 | <1% | 8,807 | $1K | |
| 0164A | <1% | 36 | $1K | |
| 93922 | <1% | 41 | $1K | |
| 73522 | <1% | 122 | $1K | |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | <1% | 1,521 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 383 | $1K |
| 11900 | <1% | 25 | $1K | |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | <1% | 1,413 | $1K |
| 99381 | <1% | 62 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 143 | $1K |
| 90473 | <1% | 328 | $1K | |
| 96158 | <1% | 35 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 622 | $1K |
| 69210 | <1% | 186 | $1K | |
| E1392 | Portable oxygen concentrator, rental | <1% | 571 | $1K |
| 83735 | <1% | 4,580 | $1K | |
| 73100 | <1% | 519 | $1K | |
| 99304 | <1% | 38 | $1K | |
| 87088 | <1% | 12,206 | $1K | |
| 97802 | <1% | 444 | $1K | |
| 84480 | <1% | 1,230 | $1K | |
| 86140 | <1% | 6,145 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 8,869 | $1K |
| T4534 | Youth sized disposable incontinence product, protective underwear/pull-on, each | <1% | 872 | $1K |
| 83550 | <1% | 8,921 | $1K | |
| 90838 | <1% | 28 | $1K | |
| 84520 | <1% | 10,219 | $1K | |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | <1% | 74 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 628 | $1K |
| 90696 | <1% | 937 | $1K | |
| 97803 | <1% | 83 | $1K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 678 | $964.44 |
| 84403 | <1% | 2,525 | $960.96 | |
| 87210 | <1% | 1,762 | $928.52 | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 28 | $922.00 |
| 82607 | <1% | 8,021 | $915.32 | |
| 83540 | <1% | 8,940 | $889.46 | |
| 90885 | <1% | 472 | $882.46 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,643 | $868.02 |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 53 | $850.89 |
| 73600 | <1% | 150 | $835.24 | |
| 76885 | <1% | 27 | $834.49 | |
| 84075 | <1% | 7,708 | $834.26 | |
| 86665 | <1% | 789 | $820.02 | |
| 90632 | <1% | 27 | $820.00 | |
| 82247 | <1% | 7,459 | $815.28 | |
| 90700 | <1% | 1,031 | $792.91 | |
| 77072 | <1% | 104 | $781.68 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,038 | $781.34 |
| 96415 | <1% | 160 | $777.04 | |
| 17999 | <1% | 454 | $776.00 | |
| 84100 | <1% | 3,835 | $767.54 | |
| 95806 | <1% | 93 | $694.00 | |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 1,049 | $689.04 |
| 85027 | <1% | 19,194 | $684.74 | |
| 82947 | <1% | 13,691 | $680.96 | |
| 87070 | <1% | 2,257 | $679.14 | |
| 92555 | <1% | 68 | $664.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 314 | $663.30 |
| 82570 | <1% | 3,911 | $660.29 | |
| 86360 | <1% | 332 | $651.84 | |
| 90836 | <1% | 24 | $637.92 | |
| 87209 | <1% | 1,631 | $620.34 | |
| 70250 | <1% | 150 | $619.39 | |
| D1206 | Topical application of fluoride varnish | <1% | 1,050 | $616.30 |
| 73020 | <1% | 107 | $606.43 | |
| 83993 | <1% | 571 | $585.09 | |
| 92587 | <1% | 119 | $578.00 | |
| 90707 | <1% | 325 | $564.25 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,713 | $561.70 |
| 86480 | <1% | 1,027 | $560.00 | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 952 | $550.00 |
| 73060 | <1% | 26 | $547.84 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 960 | $534.90 |
| 83655 | <1% | 1,790 | $532.63 | |
| 90716 | <1% | 232 | $532.04 | |
| 82784 | <1% | 1,547 | $510.72 | |
| 70460 | <1% | 17 | $505.19 | |
| 82310 | <1% | 6,653 | $504.30 | |
| 93308 | <1% | 13 | $494.58 | |
| 86780 | <1% | 8,858 | $493.50 | |
| B9002 | Enteral nutrition infusion pump, any type | <1% | 26 | $481.60 |
| 82040 | <1% | 4,363 | $480.66 | |
| K0003 | Lightweight wheelchair | <1% | 115 | $477.84 |
| 82248 | <1% | 1,883 | $475.90 | |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 312 | $465.70 |
| 86803 | <1% | 7,749 | $464.90 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 504 | $461.79 |
| 72170 | <1% | 44 | $453.21 | |
| E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | <1% | 494 | $444.32 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 177 | $443.41 |
| 81025 | <1% | 4,183 | $439.90 | |
| 82043 | <1% | 5,431 | $436.90 | |
| 99462 | <1% | 212 | $434.27 | |
| 84156 | <1% | 3,306 | $424.31 | |
| 92588 | <1% | 25 | $420.00 | |
| 96159 | <1% | 16 | $396.00 | |
| 99348 | <1% | 16 | $388.52 | |
| 0173A | <1% | 57 | $374.22 | |
| E0603 | Breast pump, electric (ac and/or dc), any type | <1% | 412 | $372.60 |
| 73521 | <1% | 75 | $363.47 | |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 599 | $362.38 |
| 86664 | <1% | 789 | $353.19 | |
| 86160 | <1% | 114 | $348.24 | |
| 87329 | <1% | 1,591 | $322.92 | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 36 | $320.40 |
| 87340 | <1% | 6,462 | $319.72 | |
| 80069 | <1% | 768 | $305.66 | |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 2,574 | $300.00 |
| 86225 | <1% | 542 | $296.79 | |
| 81002 | <1% | 2,656 | $295.49 | |
| 76827 | <1% | 24 | $290.00 | |
| 90658 | <1% | 1,529 | $289.47 | |
| 83690 | <1% | 2,724 | $288.42 | |
| 97167 | <1% | 91 | $282.00 | |
| 76937 | <1% | 13 | $280.00 | |
| E0143 | Walker, folding, wheeled, adjustable or fixed height | <1% | 246 | $279.05 |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | <1% | 12 | $274.70 |
| 85610 | <1% | 5,228 | $272.77 | |
| 96113 | <1% | 12 | $264.00 | |
| 90713 | <1% | 106 | $260.00 | |
| 99091 | <1% | 360 | $259.00 | |
| 94760 | <1% | 480 | $254.59 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 12 | $246.56 |
| 82150 | <1% | 1,276 | $237.36 | |
| 84146 | <1% | 1,678 | $220.82 | |
| 88341 | <1% | 222 | $196.40 | |
| G9012 | Other specified case management service not elsewhere classified | <1% | 4,954 | $195.00 |
| 84550 | <1% | 2,994 | $193.25 | |
| 82670 | <1% | 697 | $189.41 | |
| 88344 | <1% | 27 | $184.24 | |
| 86706 | <1% | 2,947 | $178.85 | |
| 98971 | <1% | 12 | $177.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 367 | $176.65 |
| G9920 | Screening performed and negative | <1% | 30,899 | $174.51 |
| 76801 | <1% | 13 | $166.48 | |
| 84132 | <1% | 16,003 | $161.68 | |
| 87102 | <1% | 1,651 | $159.36 | |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 3,180 | $150.00 |
| 82977 | <1% | 474 | $150.00 | |
| 86038 | <1% | 592 | $146.90 | |
| 83001 | <1% | 1,220 | $146.14 | |
| 99305 | <1% | 45 | $146.00 | |
| 87529 | <1% | 283 | $145.67 | |
| 82550 | <1% | 1,068 | $140.10 | |
| 82746 | <1% | 501 | $140.02 | |
| 90474 | <1% | 317 | $139.00 | |
| 86704 | <1% | 1,993 | $137.93 | |
| 70360 | <1% | 20 | $135.02 | |
| 99070 | <1% | 14 | $132.20 | |
| 84295 | <1% | 8,838 | $129.87 | |
| 82105 | <1% | 411 | $120.30 | |
| 98966 | <1% | 28 | $120.00 | |
| 83615 | <1% | 973 | $116.83 | |
| 86376 | <1% | 232 | $116.49 | |
| A0130 | Non-emergency transportation: wheelchair van | <1% | 1,573 | $111.20 |
| 92132 | <1% | 12 | $108.00 | |
| 96116 | <1% | 16 | $107.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 8,865 | $105.73 |
| 88142 | <1% | 6,585 | $88.02 | |
| 82533 | <1% | 153 | $86.94 | |
| 82627 | <1% | 392 | $76.64 | |
| 82465 | <1% | 913 | $76.10 | |
| 90756 | <1% | 14 | $74.12 | |
| 80164 | <1% | 80 | $71.93 | |
| 17000 | <1% | 13 | $69.80 | |
| 83002 | <1% | 473 | $63.95 | |
| 80197 | <1% | 19 | $61.05 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 173 | $59.51 |
| 11100 | <1% | 165 | $58.89 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $55.84 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 364 | $52.38 |
| 83721 | <1% | 1,393 | $49.32 | |
| 76870 | <1% | 42 | $46.81 | |
| 83498 | <1% | 80 | $45.66 | |
| 86787 | <1% | 1,069 | $45.52 | |
| 86328 | <1% | 164 | $45.23 | |
| 85018 | <1% | 2,243 | $44.46 | |
| 92551 | <1% | 13 | $44.00 | |
| 85014 | <1% | 2,274 | $43.53 | |
| 99417 | Prolong home eval add 15m | <1% | 60 | $43.38 |
| A4520 | Incontinence garment, any type, (e.g., brief, diaper), each | <1% | 256 | $42.88 |
| 86769 | <1% | 35 | $42.13 | |
| 87081 | <1% | 1,545 | $39.76 | |
| 86762 | <1% | 1,749 | $38.51 | |
| 82950 | <1% | 1,742 | $37.32 | |
| 90660 | <1% | 13 | $37.00 | |
| 97116 | <1% | 33 | $33.84 | |
| 84153 | <1% | 2,595 | $31.06 | |
| 90744 | <1% | 125 | $30.60 | |
| 84165 | <1% | 714 | $28.68 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 329 | $28.02 |
| 86431 | <1% | 540 | $19.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 726 | $15.52 |
| 86200 | <1% | 219 | $14.20 | |
| A4927 | Gloves, non-sterile, per 100 | <1% | 740 | $13.97 |
| 84702 | <1% | 153 | $13.24 | |
| 86765 | <1% | 185 | $11.45 | |
| 86709 | <1% | 12 | $9.91 | |
| 86708 | <1% | 253 | $9.91 | |
| 86901 | <1% | 1,664 | $9.77 | |
| 86900 | <1% | 1,662 | $9.52 | |
| 87338 | <1% | 223 | $8.40 | |
| 85007 | <1% | 25 | $8.13 | |
| 86850 | <1% | 1,465 | $7.80 | |
| 85008 | <1% | 453 | $7.28 | |
| 17110 | <1% | 467 | $7.06 | |
| 84630 | <1% | 138 | $7.00 | |
| 84703 | <1% | 801 | $6.46 | |
| E0604 | Breast pump, hospital grade, electric (ac and / or dc), any type | <1% | 2,685 | $5.44 |
| 85045 | <1% | 13 | $3.55 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 299 | $2.29 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 12 | $1.54 |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | <1% | 26 | $1.36 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 135 | $0.00 |
| 1036F | 0% | 55,679 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 58 | $0.00 |
| K0738 | Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing | 0% | 522 | $0.00 |
| A7037 | Tubing used with positive airway pressure device | 0% | 2,058 | $0.00 |
| 82525 | 0% | 79 | $0.00 | |
| 3074F | 0% | 37 | $0.00 | |
| 84478 | 0% | 107 | $0.00 | |
| 11102 | 0% | 69 | $0.00 | |
| A7030 | Full face mask used with positive airway pressure device, each | 0% | 822 | $0.00 |
| A7032 | Cushion for use on nasal mask interface, replacement only, each | 0% | 326 | $0.00 |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 11,783 | $0.00 |
| 99024 | 0% | 390 | $0.00 | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 0% | 155 | $0.00 |
| 80178 | 0% | 374 | $0.00 | |
| 73501 | 0% | 35 | $0.00 | |
| 58300 | 0% | 310 | $0.00 | |
| 90732 | 0% | 719 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 51 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 140 | $0.00 |
| 82985 | 0% | 115 | $0.00 | |
| 82435 | 0% | 155 | $0.00 | |
| 82378 | 0% | 58 | $0.00 | |
| 97162 | 0% | 12 | $0.00 | |
| 57454 | 0% | 53 | $0.00 | |
| 86304 | 0% | 94 | $0.00 | |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | 0% | 54 | $0.00 |
| 95115 | 0% | 173 | $0.00 | |
| 58301 | 0% | 40 | $0.00 | |
| A0999 | Unlisted ambulance service | 0% | 783 | $0.00 |
| 58100 | 0% | 183 | $0.00 | |
| 97035 | 0% | 104 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 29 | $0.00 |
| 90381 | 0% | 13 | $0.00 | |
| 87536 | 0% | 12 | $0.00 | |
| 87040 | 0% | 12 | $0.00 | |
| 96150 | 0% | 17 | $0.00 | |
| K0739 | Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes | 0% | 28 | $0.00 |
| 83020 | 0% | 26 | $0.00 | |
| 83718 | 0% | 161 | $0.00 | |
| A0170 | Transportation ancillary: parking fees, tolls, other | 0% | 5,428 | $0.00 |
| 82274 | 0% | 6,454 | $0.00 | |
| 81329 | 0% | 413 | $0.00 | |
| 84425 | 0% | 382 | $0.00 | |
| A7046 | Water chamber for humidifier, used with positive airway pressure device, replacement, each | 0% | 1,153 | $0.00 |
| A7035 | Headgear used with positive airway pressure device | 0% | 2,412 | $0.00 |
| 86677 | 0% | 373 | $0.00 | |
| A7038 | Filter, disposable, used with positive airway pressure device | 0% | 2,462 | $0.00 |
| 90714 | 0% | 375 | $0.00 | |
| 86735 | 0% | 107 | $0.00 | |
| A7034 | Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap | 0% | 1,732 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 105 | $0.00 |
| 96153 | 0% | 52 | $0.00 | |
| A7031 | Face mask interface, replacement for full face mask, each | 0% | 349 | $0.00 |
| 54150 | 0% | 26 | $0.00 | |
| V2020 | Frames, purchases | 0% | 620 | $0.00 |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 0% | 69 | $0.00 |
| A7033 | Pillow for use on nasal cannula type interface, replacement only, pair | 0% | 245 | $0.00 |
| S5199 | Personal care item, nos, each | 0% | 334 | $0.00 |
| 84207 | 0% | 13 | $0.00 | |
| 90746 | 0% | 144 | $0.00 | |
| 82374 | 0% | 157 | $0.00 | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 0% | 114 | $0.00 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 156 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 520 | $0.00 |
| 73000 | 0% | 20 | $0.00 | |
| V2750 | Anti-reflective coating, per lens | 0% | 206 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 24 | $0.00 |
| 96900 | 0% | 782 | $0.00 | |
| H0032 | Mental health service plan development by non-physician | 0% | 624 | $0.00 |
| 92552 | 0% | 38 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 88 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 17 | $0.00 |
| 3078F | 0% | 52 | $0.00 | |
| 90461 | 0% | 12 | $0.00 | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 0% | 30 | $0.00 |
| 51701 | 0% | 12 | $0.00 | |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | 0% | 54 | $0.00 |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 0% | 12 | $0.00 |
| 96367 | 0% | 14 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 28 | $0.00 |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEST, PATRICIA (CHIEF FINANCIAL OFFICER)
Parent organizationPERMANENTE MEDICAL GROUP, INC.
| Provider | Location | Paid |
|---|---|---|
| Permanente Medical Group, INC. | Richmond, CA | $51.11M |
| Permanente Medical Group INC | Richmond, CA | $37.82M |
| Permanente Medical Group, INC. | Berkeley, CA | $31.35M |
| Permanente Medical Group INC | Vallejo, CA | $16.13M |
| Permanente Medical Group INC | Santa Clara, CA | $8.46M |
| Permanente Medical Group INC | San Francisco, CA | $5.40M |
| Permanente Medical Group INC | Redwood City, CA | $4.45M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.